Consytel Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.13 M
- Revenue Growth 6.37%
- Profit Growth 10.91%
- Ebitda 11.63%
- Net Worth 22.86%
- Total Assets 165.75%
About Consytel Life Sciences
Consytel Life Sciences Private Limited (CLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 December 2017 (Seven years and one month 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.13 M.
Shubhendu Dash, Sandhyarani Dash, Swagatika Satpathy, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290TG2017PTC121396
-
Company No.
121396
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Dec 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Consytel Life Sciences Private Limited offer?
Consytel Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Consytel Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhendu Dash
|
Director | 22-Dec-2017 | Current |
|
Sandhyarani Dash
|
Director | 22-Dec-2017 | Current |
|
Swagatika Satpathy
|
Director | 01-Nov-2019 | Current |
|
Saurabh Dash
|
Director | 04-Nov-2022 | Current |
Financial Performance of Consytel Life Sciences.
Consytel Life Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.37% increase. The company also saw a substantial improvement in profitability, with a 10.91% increase in profit. The company's net worth Soared by an impressive increase of 22.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consytel Life Sciences?
In 2022, Consytel Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.13 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Uco Bank | ₹1.13 M | Open |
How Many Employees Work at Consytel Life Sciences?
Unlock and access historical data on people associated with Consytel Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consytel Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consytel Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.